Home/Filings/4/0001144204-13-022168

4//SEC Filing

SANDERLING V LTD PARTNERSHIP 4

Accession 0001144204-13-022168

CIK 0001117480other

View on SEC.gov Company Profile

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 4:29 PM ET

Size

66.8 KB

Accession

0001144204-13-022168

Insider Transaction Report

Form 4

Period: 2013-04-16

CHIMERIX INCCMRX

SANDERLING V BETEILIGUNGS GMBH & CO KG

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)

SANDERLING VENTURES MANAGEMENT V

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)

Sanderling Venture Partners V Co Investment Fund, LP

10% Owner

Transactions

Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)

Sanderling V Strategic Exit Fund LP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)

Sanderling Venture Partners VI Co Investment Fund LP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)

Sanderling VI Beteiligungs GmbH & Co KG

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)

Sanderling Venture Partners V, LP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)

SANDERLING V BIOMEDICAL LP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)

SANDERLING V LTD PARTNERSHIP

10% Owner

Transactions

Conversion
Common Stock
2013-04-16+183,096→ 183,096 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+695,496→ 1,822,402 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+792,037→ 4,143,152 total(indirect: See Footnote)
Conversion
Series E Preferred Stock
2012-04-16−2,200,490→ 0 total(indirect: See Footnote)
→ Common Stock (619,852 underlying)
Conversion
Series C Preferred Stock
2012-04-16−2,469,034→ 0 total(indirect: See Footnote)
→ Common Stock (695,496 underlying)
Conversion
Series F Preferred Stock
2012-04-16−2,811,735→ 0 total(indirect: See Footnote)
→ Common Stock (792,037 underlying)
Conversion
Common Stock
2013-04-16+474,330→ 657,426 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+469,480→ 1,126,906 total(indirect: See Footnote)
Conversion
Common Stock
2013-04-16+771,372→ 2,593,774 total(indirect: See Footnote)
Conversion
Series B Preferred Stock
2012-04-16−1,683,879→ 0 total(indirect: See Footnote)
→ Common Stock (474,330 underlying)
Conversion
Series D Preferred Stock
2012-04-16−2,738,386→ 0 total(indirect: See Footnote)
→ Common Stock (771,372 underlying)
Conversion
Common Stock
2013-04-16+619,852→ 3,213,626 total(indirect: See Footnote)
Conversion
Series B-1 Preferred Stock
2012-04-16−1,666,667→ 0 total(indirect: See Footnote)
→ Common Stock (469,480 underlying)
Conversion
Series A Preferred Stock
2012-04-16−650,000→ 0 total(indirect: See Footnote)
→ Common Stock (183,096 underlying)

Footnotes (9)

[F1]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series A Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F2]See attached Exhibit 99.1
[F3]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series B Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F4]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series B-1 Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F5]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series C Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F6]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series D Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F7]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series E Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F8]Upon the closing of the Issuer's initial public offering, every 3.55 shares of Series F Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
[F9]Includes 137,489 shares issued as payment of accrued dividends on the Series F Preferred Stock.

Documents

3 files

Issuer

CHIMERIX INC

CIK 0001117480

→

Entity typeother

Related Parties

filerCIK 0001267960

Filing Metadata

Form type: 4
Filed: Apr 15, 8:00 PM ET
Accepted: Apr 16, 4:29 PM ET
Size: 66.8 KB

View on SEC.gov